Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 8,688	$ 9,291
Prepaid expenses and other current assets	1,508	1,273
Other receivables	472	744
Total current assets	10,668	11,308
Restricted cash	5,390	5,480
Property and equipment, net	12,194	13,241
Operating lease right-of-use asset	33,911	41,687
In-process research and development	10,256	10,256
Goodwill	3,490	3,490
Other assets	973	975
Total assets	76,882	86,437
Current liabilities
Accounts payable and accrued liabilities	1,705	2,055
Accrued compensation	2,191	2,280
Term debt, current		38,954
Current portion of operating lease liabilities	4,564	4,431
Other current liabilities	487	529
Total current liabilities	8,947	48,249
Convertible Loan, non-current	153,860	32,897
Term debt, non-current	103,061	22,539
Operating lease liabilities, net of current portion	26,533	27,694
Deferred tax liability	3,077	3,077
Total liabilities	295,478	134,456
Commitments and contingencies (Note 12)
Stockholders' deficit
Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,431,444 and 36,183,067 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	364	362
Additional paid-in capital	282,574	279,354
Accumulated deficit	(501,534)	(327,735)
Total stockholders' deficit	(218,596)	(48,019)	$ (32,065)
Total liabilities and stockholders' deficit	$ 76,882	$ 86,437